Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | P2RX4 | Q99571 | 9/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15434786 | 0.93 | KMT2A (0.36) | KMT2ACYP1A2CYP2D6P2RX4MAPT | |
| SCHEMBL12723354 | 0.90 | MAPT (0.37) | KMT2ACYP1A2CYP2D6P2RX4MAPT | |
| SCHEMBL9886660 | 0.88 | MAPT (0.34) | KMT2ACYP1A2CYP2D6P2RX4MAPT | |
| SCHEMBL9886636 | 0.88 | MAPT (0.34) | KMT2ACYP1A2CYP2D6P2RX4MAPT | |
| SCHEMBL12165670 | 0.87 | LMNA (0.34) | KMT2ACYP1A2CYP2D6P2RX4MAPT | |
| SCHEMBL9886644 | 0.87 | MAPT (0.33) | KMT2AP2RX4MAPTSMN1; SMN2HTT | |
| SCHEMBL9886694 | 0.87 | MAPT (0.33) | KMT2AP2RX4MAPTSMN1; SMN2HTT | |
| SCHEMBL9886702 | 0.87 | MAPT (0.33) | KMT2ACYP1A2CYP2D6P2RX4MAPT | |
| SCHEMBL9886720 | 0.87 | MAPT (0.33) | KMT2ACYP1A2CYP2D6P2RX4MAPT | |
| SCHEMBL9886662 | 0.86 | MAPT (0.32) | KMT2ACYP1A2CYP2D6P2RX4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220135597-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-05-05 | — | — | US | disclosed |
| US-11264575-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2022-03-01 | — | — | US | disclosed |
| US-10008673-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2018-06-26 | — | — | US | disclosed |
| US-20170155062-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-06-01 | — | — | US | disclosed |
| US-9130173-B2 | Quinolino[3,2,1-kl]phenoxazine compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2015-09-08 | — | — | US | disclosed |
| US-9130173-B2 | Quinolino[3,2,1-kl]phenoxazine compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20130228768-A1 | QUINOLINO[3,2,1-KL]PHENOXAZINE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130228768-A1 | QUINOLINO[3,2,1-KL]PHENOXAZINE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20120319052-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | disclosed |
| WO-2011107186-A2 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11264575-B2 | Compounds for electronic devices | CYP2C19, CYP2C18, CYP1B1 | KMT2A 2159/4885CYP1A2 7/4885CYP2D6 16/4885 |
| US-20170155062-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP1B1, CYP1A1, CYP2E1 | KMT2A 1564/4885CYP1A2 5/4885CYP2D6 4/4885 |
| US-10008673-B2 | Compounds for electronic devices | CYP1B1, CYP1A1, CYP2E1 | KMT2A 1564/4885CYP1A2 5/4885CYP2D6 4/4885 |
| US-20220135597-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OCIAD1, ODC1 | KMT2A 4272/4885CYP1A2 244/4885CYP2D6 148/4885 |
| US-20120319052-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP1B1, CYP1A1, CYP2E1 | KMT2A 1564/4885CYP1A2 5/4885CYP2D6 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.